Shakespeare Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $263K | Sell |
1,419
-544
| -28% | -$101K | 0.07% | 84 |
|
|
2025
Q1 | $411K | Buy |
1,963
+9
| +0.5% | +$1.89K | 0.11% | 71 |
|
|
2024
Q4 | $347K | Buy |
1,954
+39
| +2% | +$6.93K | 0.09% | 74 |
|
|
2024
Q3 | $378K | Buy |
1,915
+10
| +0.5% | +$1.98K | 0.1% | 71 |
|
|
2024
Q2 | $327K | Buy |
1,905
+8
| +0.4% | +$1.37K | 0.09% | 72 |
|
|
2024
Q1 | $345K | Buy |
1,897
+90
| +5% | +$16.4K | 0.1% | 67 |
|
|
2023
Q4 | $280K | Hold |
1,807
| – | – | 0.09% | 70 |
|
|
2023
Q3 | $269K | Hold |
1,807
| – | – | 0.09% | 67 |
|
|
2023
Q2 | $243K | Buy |
1,807
+6
| +0.3% | +$808 | 0.08% | 68 |
|
|
2023
Q1 | $287K | Buy |
1,801
+174
| +11% | +$27.7K | 0.1% | 62 |
|
|
2022
Q4 | $263K | Buy |
+1,627
| New | +$263K | 0.1% | 63 |
|
|
2022
Q3 | – | Sell |
-1,413
| Closed | -$218K | – | 68 |
|
|
2022
Q2 | $218K | Buy |
1,413
+11
| +0.8% | +$1.7K | 0.09% | 66 |
|
|
2022
Q1 | $227K | Buy |
+1,402
| New | +$227K | 0.08% | 71 |
|